Event Sponsors

ChinaBio® Events

BioBay Investor Forum 2010

Suzhou, China

Nov. 3-4, 2010

China Forum 2010

Munich, Germany

November 14, 2010

ChinaBio® Investor Forum 2010 - Guangzhou

Guangzhou, China

December 21, 2010

Partner Events

BioPharm America™ 2010

Boston, MA, USA

September 15–17, 2010

CALAsia 2010

San Diego, USA

October 4-5, 2010

speakers

The ChinaBio® Investor Forum features speakers from the US and China that are renowned experts in their fields, including:

  • The State of the China Biotech Industry - China's biotech and life science industry is rapidly becoming a global force.  And it is the fastest growing industry segment in VC investment.
  • Attacting Capital - Learn what US and China investors are looking for in early and mid-stage biotechnology, pharmaceutical and life science companies, and what types of companies are bringing in funding.
  • Global Corporate Structure - How to set up a global biotech in China using US, BVI, Cayman, WFOE, holding companies, subsidiaries, etc.
  • International Intellectual Property - How to create a patent portfolio that will protect your intellectual property globally.
  • Outsourcing - How to reduce your costs and improve the return on investment by using CROs and CMOs to perform much of the work in drug development. 
Speaker List
The following industry experts will be providing insights into China's emerging biotechnology industry and how to launch and build a successful life science companies at the ChinaBio® Investor Forum.  (Click here for Speaker Bios.)
 
Keynote Speakers:
George Chen, PhD - Area VP, GlaxoSmithKline (GSK) China/HK Medical and Clinical Research
Daxu Fu, PhD - CTO, Shanghai Centre of Research & Development of New Drugs
Shouchun Zhu (朱守淳) - Vice General Manager, Zhangjiang Group, Zhangjiang Hi-Tech Park
 
Speakers and Panelists:
Charles Hsu, PhD, MBA - Partner, Bay City Capital; Co-founder, LEAD Therapeutics
Jason (Gang) Jin, PhD - President/CEO, MaxyBio Corporation; SVP Shanghai BioChip Co. Ltd.
Kevin Li, PhD - Partner, HBM BioMed China
Yuwen Liu - Vice President, Suzhou Industrial Park / BioBay / Suzhou Venture Group
Dongxu Qiu, PhD, MBA - President and Founder, BioOperations Consulting, Inc. 
Greg B. Scott – President and founder, ChinaBio™ Accelerator
Aron Stern - CFO, Vital Therapies, Inc.
Zhaohui (Zoe) Wang, PhD, JD - Partner, Perkins Coie LLP
Michael Warnecke, JD - Partner, Perkins Coie LLP
Don Williams, JD - Partner, Wilson Sonsini Goodrich & Rosati
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Fan Zhang, MBA - Founding Managing Partner, Sequoia Capital
Qiang (Sean) Zhang, PhD - Principal, BioVeda, China
Kan Zu - Partner, Unitalen Attorneys at Law

 

Presenting Companies
The following companies will be presenting at the ChinaBio® Investor Forum on Wednesday, Dec. 5:

Company / Speaker

 
Description
ABMax (Beijing)
Le Sun, PhD, CEO
Custom monoclonal antibody services 
ACCB Biotech (Beijing)
Xu Junpu, MBA, CEO
Molecular diagnostics and personalized therapy for cancer
AQChem (Shanghai)
Jack Lu, PhD, CEO
Drug discovery chemical products and services
AutekBio (Beijing)
Julius Li, MBA, CEO
Contract manufacturing of biologic products
ChinaBio Therapeutics (SH)
Greg Scott, CEO
Drug development leveraging China's low cost/high quality infrstructure
Chiral Quest, Inc. (Jiashan)
Xumu Zhang, PhD, CTO
Contract manufacturing of chiral drug candidates
Crown Bioscience, Inc. (Beijing)
William Pan, PhD, President
In vivo pharmacology and monoclonal antibody services
Fountain Medical Dev. (Tianjin)
Dan Zhang, PhD, CEO
Contract clinical trial management services
GenePharma (Suzhou)
Peter Zhang, PhD, CEO
siRNA products and chemical synthesis services
Generon Corporation (Shanghai)
Yu Liang Huang, PhD, CEO
Drug development for obesity
LEAD Therapeutics (Shanghai)
Charles Hsu, PhD, CEO
Chemistry-driven small molecule drug discovery company
MicuRX Pharmaceutical (SH)
Zhengyu Yuan, PhD, CEO
Development of anti-infective medicines
Mgene, Inc. (Shanghai)
Ahmed Bouzidi, PhD, CEO
Development of drugs for malaria, Hep-C and HIV
PanAsia Bio (Shanghai)
Michael Xu, PhD, President
Pegylation technology and PEG-based drug development
Shanghai BioChip (Shanghai)
Jason Jin, PhD, EVP
Biological drug discovery services with GLP, GCP and GMP labs
Sirnaomics, Inc. (US/China)
Patrick Lu, PhD, CEO
Drug development based on siRNA technologies